Total Knee Replacement Market Updates

Global Total Knee Replacement Market size was valued at USD 9.7 billion in 2023 and is poised to grow from USD 10.21 billion in 2024 to USD 15.44 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).

The total knee replacement market is fragmented, with many large and small players in the industry. To gain market share, key players are implementing business strategies such as diverse product offerings, regional expansion, partnerships, and new product launches. For instance, De Puy Synthes' VELYS Robotic-Assisted Solution for use with the ATTUNE Total Knee System received 510(k) clearance from the US FDA in January 2021. Furthermore, in January 2021, Stryker acquired OrthoSensor, Inc, a pioneer in the digital evolution of total joint replacement. This acquisition has strengthened its market position. 'Zimmer Biomet Holdings, Inc. (USA) ', 'Stryker Corporation (USA) ', 'DePuy Synthes (USA) ', 'Smith & Nephew plc (UK) ', 'B. Braun Melsungen AG (Germany) ', 'Medacta International SA (Switzerland) ', 'MicroPort Scientific Corporation (China) ', 'Exactech, Inc. (USA) ', 'Corin Group PLC (UK) ', 'Waldemar Link GmbH & Co. KG (Germany) ', 'LimaCorporate S.p.A. (Italy) ', 'Amplitude SAS (France) ', 'Mathys AG Bettlach (Switzerland) ', 'United Orthopedic Corporation (Taiwan) ', 'Baumer SA (Switzerland) ', 'Corentec Co., Ltd. (South Korea) ', 'Kyocera Medical Technologies, Inc. (Japan) ', 'ConforMIS, Inc. (USA) ', 'Medtronic plc (Ireland) ', 'OrthAlign, Inc. (USA)'

One of the major factors likely to boost demand for bone surgeries in the future is a rise in the incidence of knee osteoarthritis around the world. The rise in the adult population's diagnosis rate of knee arthritis is expected to increase demand for knee implants in the coming years. According to the Osteoarthritis Research Society International (OARSI), the pervasiveness of global knee osteoarthritis is likely to reach 5% and is expected to rise as the population ages. The rapid aging of the population, as well as the growing epidemics of obesity, are likely to fuel demand for knee replacement surgeries during the forecast period. According to the Arthritis Foundation, the annual incidence of knee osteoarthritis in the United States is highest between the ages of 55 and 64. These factors are expected to accelerate the global demand over the forecast year.

Infusing morphine directly into the shin bone may be a new way to help ease the pain of knee replacement surgery, according to the findings of a recent study of 48 patients undergoing total knee replacement. The researchers discovered that injecting morphine into the shin bone during the operation reduced post-surgery pain better than standard treatment alone.

During the forecast period, North America is expected to have the largest market share. The United States is a significant contributor to the region's Total Knee Replacement market growth. The major factors likely to boost the market growth in North America are a rise in the number of individuals diagnosed with rheumatoid arthritis and an increase in the geriatric population count. Furthermore, the rising penetration of computer-aided implant designs, robot-assisted surgeries in the United States, and favorable reimbursement scenarios are expected to propel the knee implant market in the United States during the forecast period. Because of the rise in chronic diseases such as diabetes and the prevalence of bone disease, Europe is expected to have the second-largest market share after North America. Innovations in implant material and design, the presence of major players with a robust distribution network, and rising demand for knee replacement procedures are expected to fuel the EUs knee replacement market by 2028.